Skip to main content
Article thumbnail
Location of Repository

Serum Angiopoietin-1 and -2 Levels Discriminate Cerebral Malaria from Uncomplicated Malaria and Predict Clinical Outcome in African Children

By Fiona E. Lovegrove, Noppadon Tangpukdee, Robert O. Opoka, Erin I. Lafferty, Nimerta Rajwans, Michael Hawkes, Srivicha Krudsood, Sornchai Looareesuwan, Chandy C. John, W. Conrad Liles and Kevin C. Kain
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2657207
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (1994). An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration.
    2. (2008). Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria.
    3. (2007). Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory medicators.
    4. (2008). Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients.
    5. (2006). Angiopoietins: a link between angiogenesis and inflammation.
    6. (2001). Blood-brain barrier function in cerebral malaria in Malawian children.
    7. (2004). Circulating endothelial microparticles in malawian children with severe falciparum malaria complicated with coma.
    8. (1998). Dengue and dengue hemorrhagic fever.
    9. (2004). Differentiating the pathologies of cerebral malaria by postmortem parasite counts.
    10. (2000). Distinct patterns of cytokine regulation in discrete clinical forms of Plasmodium falciparum malaria.
    11. (1989). Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria.
    12. (2005). Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS
    13. (1999). Evidence of blood-brain barrier dysfunction in human cerebral malaria.
    14. (2006). Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans.
    15. (1986). Function of the blood-cerebrospinal fluid barrier in human cerebral malaria: rejection of the permeability hypothesis.
    16. (2006). Human cerebral malaria and the blood-brain barrier.
    17. (2004). Immediate outcome and prognostic factors for cerebral malaria among children admitted to Mulago Hospital,
    18. (2006). Immunopathogenesis of cerebral malaria.
    19. (1998). Imported malaria: prospective analysis of problems in diagnosis and management.
    20. (1994). Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity.
    21. (1995). Indicators of life-threatening malaria in African children.
    22. (2006). Low levels of RANTES are associated with mortality in children with cerebral malaria.
    23. (1995). Magnetic resonance imaging of the brain in patients with cerebral malaria.
    24. (2006). Malarial retinopathy: a newly established diagnostic sign in severe malaria.
    25. (1998). Ophthalmoscopic abnormalities in adults with falciparum malaria.
    26. (2004). Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study.
    27. (2007). Plasmodium falciparum-infected erythrocytes decrease the integrity of human blood-brain barrier endothelial cell monolayers.
    28. (1997). Predictors of a fatal outcome following childhood cerebral malaria.
    29. (2007). Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS
    30. (2000). Prognostic significance of eye changes in cerebral malaria.
    31. (2004). Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls.
    32. (2000). Severe and complicated malaria. World Health Organization.
    33. (1998). Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment.
    34. (2005). Severe falciparum malaria in Gabonese children: clinical and laboratory features.
    35. (2007). Severe malaria in Cameroonian children: correlation between plasma levels of three soluble inducible adhesion molecules and TNF-alpha.
    36. (1998). Systemic endothelial activation occurs in both mild and severe malaria. Correlating dermal microvascular endothelial cell phenotype and soluble cell adhesion molecules with disease severity.
    37. (2005). The global distribution of clinical episodes of Plasmodium falciparum malaria.
    38. (2007). Thrombocytopenia and release of activated von Willebrand Factor during early Plasmodium falciparum malaria.
    39. (1990). TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria.
    40. (2003). Tumor necrosis factor alpha in the pathogenesis of cerebral malaria.
    41. (1989). Tumor necrosis factor and disease severity in children with falciparum malaria.
    42. (2006). Viral hemorrhagic fevers. Clin Lab Med 26: 345–386, viii.
    43. (2006). von Willebrand factor propeptide in malaria: evidence of acute endothelial cell activation.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.